PME - 15% trailASX:PME is in a significant uptrend, but there is not too much to support a 350x P/E valuation at these levels.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.10 AUD
115.22 M AUD
212.98 M AUD
53.08 M
About Pro Medicus, Ltd.
Sector
Industry
CEO
Sam Aaron Hupert
Website
Headquarters
Richmond
Founded
1983
ISIN
AU000000PME8
FIGI
BBG000C41NB3
Pro Medicus Ltd. engages in the development and supply of healthcare imaging software, Radiology Information System (RIS), and services to hospitals. It operates through the following geographical segments: Australia, Europe, and North America. The firm’s products include Visage 7 and Visage RIS. The company was founded by Sam Aaron Hupert and Anthony Barry Hall in 1983 and is headquartered in Richmond, Australia.
Related stocks
buying idea PMEPME has consolidate at all time high for 8 weeks now and looking to make a move. with the stop at 247.70 (50 day MA) it's a good risk to reward set up give it a go.
DISCLAIMER : The content and materials featured are for your information and education only and are not attended to address your part
Daily PME wedge pullback continuation pattern Pme looks to have formed a small wedge pullback to the 21 day moving average potentially to the 50 day, Creating a buy opportunity for a continuation of the long term trend. Looks as though once volume has spiked and fallen off on each pullback another marked in June/July the trend breaks out and co
Short on PME
PME is currently in an ascending channel with bearish RSI divergence. Has hit resistance at top of channel, stoploss above last swing high with target at next resistance level or could even come down to fill gap, moving SL to BE when safe to do so. RR 2:1
What Price Action Happens Next?With This Stock. I purchased as RSI was looking to be close to overbought. Likely too aggressive a trade without confirmation. There have been several doji candles since with not much movement.
DOes anyone have any thoughts or experience with what this might mean for upcoming price action up or
Pro Medicus Limited AnalysisSomeone requested for this chart. Here's my 2cents on it :
1. Some simple mathematics - Top is around 38 dollars, low is at 15 dollars. Now, the price is around 27 dollars. If you measure it, you are somewhere in the middle range now. That means, if the price action favours you, you can make potent
PME- PROMEDICUSInverse Head and shoulder.
Solid fundamentals.
As always not Financial advise. Do your own research.
PME Long technical analysis PT $40ASX:PME Price target is shown on the chart, extremely bullish during the pandemic.
Good luck mates, don't miss the train!
Here is a buy setup in Pro Medicus $PMEIt's a buy for me if $PME can close above the yellow line and above the 200 ma (red line).
Thus, the resistance will turn to support with three moving averages acting as support too.
There is a trendline at the bottom of the wicks which acting as support too.
Technical indicators are turning bullis
Pro Medicus - Falling Wedge - new uptrend resuming?Looks like plenty of upside for PME now the falling wedge has broken out to the upside. Furthermore a fairly major resistance/support level has also broken through suggesting a bullish trend may resume. I'm thinking this could be a good spot to get in.
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PME is 299.77 AUD — it has increased by 0.49% in the past 24 hours. Watch Pro Medicus, Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange Pro Medicus, Ltd. stocks are traded under the ticker PME.
PME stock has risen by 1.22% compared to the previous week, the month change is a −2.83% fall, over the last year Pro Medicus, Ltd. has showed a 89.66% increase.
We've gathered analysts' opinions on Pro Medicus, Ltd. future price: according to them, PME price has a max estimate of 350.00 AUD and a min estimate of 220.00 AUD. Watch PME chart and read a more detailed Pro Medicus, Ltd. stock forecast: see what analysts think of Pro Medicus, Ltd. and suggest that you do with its stocks.
PME stock is 1.33% volatile and has beta coefficient of 1.70. Track Pro Medicus, Ltd. stock price on the chart and check out the list of the most volatile stocks — is Pro Medicus, Ltd. there?
Today Pro Medicus, Ltd. has the market capitalization of 31.30 B, it has decreased by −1.53% over the last week.
Yes, you can track Pro Medicus, Ltd. financials in yearly and quarterly reports right on TradingView.
Pro Medicus, Ltd. is going to release the next earnings report on Feb 17, 2026. Keep track of upcoming events with our Earnings Calendar.
PME earnings for the last half-year are 0.61 AUD per share, whereas the estimation was 0.58 AUD, resulting in a 4.47% surprise. The estimated earnings for the next half-year are 0.68 AUD per share. See more details about Pro Medicus, Ltd. earnings.
Pro Medicus, Ltd. revenue for the last half-year amounts to 115.75 M AUD, despite the estimated figure of 115.78 M AUD. In the next half-year revenue is expected to reach 134.46 M AUD.
PME net income for the last half-year is 63.47 M AUD, while the previous report showed 51.74 M AUD of net income which accounts for 22.66% change. Track more Pro Medicus, Ltd. financial stats to get the full picture.
Pro Medicus, Ltd. dividend yield was 0.19% in 2025, and payout ratio reached 49.87%. The year before the numbers were 0.28% and 50.46% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 10, 2025, the company has 132 employees. See our rating of the largest employees — is Pro Medicus, Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Pro Medicus, Ltd. EBITDA is 164.93 M AUD, and current EBITDA margin is 77.44%. See more stats in Pro Medicus, Ltd. financial statements.
Like other stocks, PME shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pro Medicus, Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pro Medicus, Ltd. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pro Medicus, Ltd. stock shows the buy signal. See more of Pro Medicus, Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.